Florida 2025 2025 Regular Session

Florida House Bill H1545 Comm Sub / Bill

Filed 04/09/2025

                       
 
CS/CS/HB 1545  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1545-02-c2 
Page 1 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
A bill to be entitled 1 
An act relating to Parkinson's disease; creating s. 2 
1004.4352, F.S.; establishing the Consortium for 3 
Parkinson's Disease Research within the University of 4 
South Florida; establishing the Parkinson's Disease 5 
Research Board; requiring the board to direct the 6 
operations of the consortium and to annually adopt a 7 
plan for Parkinson's disease research; providing 8 
duties of the consortium director; providing research 9 
requirements for the plan; requiring the board to 10 
issue an annual report to the Governor and Legislature 11 
by a specified date; providing that specified 12 
provisions will be implemented subject to available 13 
funding in the General Appropriations Act; providing 14 
an effective date. 15 
 16 
Be It Enacted by the Legislature of the State of Florida: 17 
 18 
 Section 1.  Section 1004.4352, Florida Statutes, is created 19 
to read: 20 
 1004.4352  Parkinson's disease research. — 21 
 (1)  SHORT TITLE.—This section may be cited as the 22 
"Parkinson's Disease Research Act." 23 
 (2)  LEGISLATIVE FINDINGS. —The Legislature finds that: 24 
 (a)  Parkinson's disease is a progressive neurological 25     
 
CS/CS/HB 1545  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1545-02-c2 
Page 2 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
disorder affecting approximately one million Americans, with an 26 
estimated 90,000 new diagnoses each year. 27 
 (b)  Currently, there is no cure for Parkinson's disease 28 
and innovative research is essential to advance therapies, 29 
improve patient outcomes, and alleviate the burden of the 30 
disease. 31 
 (3)  DEFINITIONS.—As used in this section, the term: 32 
 (a)  "Board" means the Parkin son's Disease Research Board. 33 
 (b)  "Consortium" means the Consortium for Parkinson's 34 
Disease Research. 35 
 (4)  CONSORTIUM FOR PARKINSON'S DISEASE RESEARCH. — 36 
 (a)  There is established within the University of South 37 
Florida the Consortium for Parkinson's Dis ease Research which 38 
shall consist of public and private universities and academic 39 
medical centers. The purpose of the consortium is to conduct 40 
rigorous scientific research and disseminate such research. 41 
 (b)  The Parkinson's Disease Research Board is estab lished 42 
to direct the operations of the consortium. The board shall be 43 
composed of members representing each participating university 44 
or academic medical center appointed by the president or chief 45 
executive officer of each participating university or academ ic 46 
medical center. Board members must have experience in a variety 47 
of scientific fields, including, but not limited to, neurology, 48 
psychology, nutrition, and genetics. Members shall be appointed 49 
to 4-year terms and may be reappointed to serve additional 50     
 
CS/CS/HB 1545  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1545-02-c2 
Page 3 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
terms. The chair shall be elected by the board from among its 51 
members to serve a 2 -year term. The board shall meet at least 52 
semiannually at the call of the chair or, in his or her absence 53 
or incapacity, the vice chair. Four members constitute a quorum. 54 
A majority vote of the members present is required for all 55 
actions of the board. The board may prescribe, amend, and repeal 56 
a charter governing the manner in which it conducts its 57 
business. Board members shall serve without compensation, but 58 
are entitled to receive reimbursement for travel expenses by the 59 
consortium or the organization he or she represents in 60 
accordance with s. 112.061. 61 
 (c)  The consortium shall be administered by a director, 62 
who shall be appointed by and serve at the pleasure of the 63 
board. The director shall, subject to the approval of the board: 64 
 1.  Propose a budget for the consortium. 65 
 2.  Foster the collaboration of scientists, researchers, 66 
and other appropriate personnel in accordance with the 67 
consortium's charter. 68 
 3.  Engage individuals in public and private university and 69 
academic medical center programs relevant to the consortium's 70 
work to participate in the consortium. 71 
 4.  Identify and prioritize the research to be conducted by 72 
the consortium. 73 
 5.  Prepare a plan for Parkinson's disea se research for 74 
submission to the board. 75     
 
CS/CS/HB 1545  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1545-02-c2 
Page 4 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
 6.  Apply for grants to obtain funding for research 76 
conducted by the consortium. 77 
 7.  Perform other duties as determined by the board. 78 
 (d)  The board shall annually adopt a plan for Parkinson's 79 
disease research. The plan must organize a program of research 80 
that contributes to the body of scientific knowledge on the 81 
causes, mechanisms, and potential treatments for Parkinson's 82 
disease and the prevalence of Parkinson's disease in first 83 
responders. The board must award funds to members of the 84 
consortium to perform research consistent with the plan. 85 
 (e)  By October 15 of each year, the board shall issue a 86 
report to the Governor, the President of the Senate, and the 87 
Speaker of the House of Representatives on research pro jects, 88 
research findings, community outreach initiatives, and future 89 
plans for the consortium. 90 
 (f)  The provisions of this section shall be implemented to 91 
the extent of available appropriations contained in the annual 92 
General Appropriations Act for such p urpose. 93 
 Section 2. This act shall take effect July 1, 2025. 94